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LONG-TERM RESULTS OF
CHOLEDOCHODUODENOSTOMY
ABSTRACT
Escudero-Fabre, A., Escallon, A., Sack, J., Halpern, N.B., Aldrete, J.S. (1991)
Cholodechoduodenostomy. Analysis of 71 cases followedfor 5 to 15 years. Annuals
of Surgery; 213: 635-644.
To investigate the long-term effectiveness of choledochoduodenostomy (CDD), the
experience with 71 patients followed for 5 or more years after CDD was analyzed
retrospectively. From 1968 to 1984, 134 patients underwent CDD. Eight patients
(6%) died in the immeditate postoperative period, 55 left the hospital, 8 ofthem were
lost to follow-up, and 47 were followed but died before 5 years elapsed after CDD.
The remaining 71 patients form the date base for this analysis: 38 were followed for
more than 5 years, 25 were followed for more than 10 years and 8 were followed for
more than 15 years ( 12.1 years _
1.3 SEM). Choledocholithiasis, chronic
pancreatitis and postoperative stricture were the indications for CDD. Cholangitis
was observed in only three patients. The diameter of the common bile duct (CBD)
was large in most patients ( 18 mm _
0.9 SEM). These results infer that CDD is
effective to treat non-neoplastic obstructing lesions of the distal CBD on a long-term
basis and that the presence of a dilated CBD (more than 16 mm) that allows the
construction of a CDD more than 14 mm is essential to obtain good results.
PAPER DISCUSSION
KEY WORDS: Choledocholithiasis, choledochoduodenostomy
The role of biliary tract surgery has come under considerable scrutiny since the
advent of therapeutic endoscopic retrograde cholangiopancreatography (ERCP)
and more recently that of laparoscopic cholecystectomy. One of the arguments that
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could be effectively used against the routine use of endoscopic sphinctermotomy
(ES) and bile duct stone extraction was the 10-20% risk to the patients of
developing subsequent gallbladder symptoms including chronic cholecystitis and
empyema of the gall bladder 1. On the existing evidence it would appear that a
combination of ES and laparoscopic cholecystectomy
2 would be preferable to open
surgery. Laparoscopic choledocholithotomy can be performed but the success rate
is likely to be higher with ES, a procedure associated with a low morbidity and
mortality . Although this should not be completely pre-judged, particularly since a
prospective trial failed to show a superior advantage of ES combined with conven-
tional cholecystectomy over surgery alone , the concept of minimally-invasive
surgery is likely to be preferred by patients.
In deciding treatment options both the immediate post-procedural and long-term
complications need to be compared. Whereas there is reasonably good comparative
data for the former, good long-term results are relatively lacking both with regards
to surgical choledocholithotomy and to endoscopic treatment. These arguments
apply equally to the definitive treatment of bile duct stones by percutaneous
techniques 4. Not withstanding the lack of any long-term data, percutaneous
methods are likely to be inferior given the relatively poor initial success rates and
high complication rates; such arguments may not apply in the context of recurrent
pyogenic cholangitis and intrahepatic duct calculi.
This contribution of Escudero-Fabre and colleagues contains dataof considerable
importance to these arguments. This is an enjoyable paper, well written and
excellently referenced. The series is, however, slightly confused by including a
number of patients known to have had cancer at the time of initial surgery. It is
preferable to exclude these and consider only these 104 patients operated on for
presumed benign disease. In this group, there were three (2.9%) post-operative
deaths; eight patients were lost to follow-up; thirteen died up to 5 years from
unrelated causes; nine died of malignancy (in six cases due to pancreatico-biliary
cancer). There remained 71 patients who were followed up for 5-15 years (mean
12.1 years) of whom three (4.2%) developed attacks of acute cholangitis; one had
one attack managed conservatively, another had multiple attacks until a metal stent
was inserted percutaneously and a third died from liver failure as a consequence of
(primary) sclerosing cholangitis.
The results confirm the relatively low mortality of this operation. Originally this
was performed by Sprengel in 1891 and not by Riedel in 1888 as is so often
quoted. It was extensively used with considerable success by German surgeons but
curiously it was subsequently rejected by them because of the fear of recurrent
cholangitis but detailed evidence of this was lacking. The overall incidence of long-
term complications reported by Escudero-Fabre et al. is consistent with several
studies involving detailed long-term follow-up of choledochoduodenostomy all
showing an incidence of sump syndrome and/or cholangitis of <5%
7,8, 10. Most of
these complications are readily dealt with by endoscopic treatment t. t2. The data
on post-procedural mortality and long-term results are similar to those reported for
endoscopic sphincterotomy as the primary treatment 1.
Of particular concern was the finding that six (5.7%) patients had pancreaticobi-
liary tumours unsuspected at the time of choledochoduodenostomy. Thomas et al.
3 reported a similar incidence of 5% in 1971 and Baker et al. had an incidence of
3.7%. Since these tumours could not be readily differentiated from the oedema in
the pancreatic head caused by impacted gallstones, it suggests that they were allHPB INTERNATIONAL 159
resectable. This further supports the argument for detailed pre-operative investi-
gation in all patients presenting with obstructive jaundice preferably by ERCP.
Choledochoduodenostyomy has a definite role in the management of bile duct
stones. The proportion of cases requiring this approach is diminishing because of
non-operative techniques but it will not be eliminated by them based on current
trends.
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